Rankings
▼
Calendar
FATE Q1 2021 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$142M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
+343.0% YoY
Gross Profit
-$34M
-302.5% margin
Operating Income
-$46M
-414.7% margin
Net Income
-$45M
-404.7% margin
EPS (Diluted)
$-0.48
QoQ Revenue Growth
-29.9%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$31M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$256M
Stockholders' Equity
$790M
Cash & Equivalents
$106M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$3M
+343.0%
Gross Profit
-$34M
-$27M
-26.0%
Operating Income
-$46M
-$34M
-34.0%
Net Income
-$45M
-$34M
-34.5%
Revenue Segments
Upfront Fee And Equity Premium
$2M
100%
← FY 2021
All Quarters
Q2 2021 →